Assay development is a fundamental part of modern drug discovery, preclinical research, and clinical development. A well-designed assay gives researchers a dependable way to detect, measure, or evaluate a biological target, compound, biomarker, or therapeutic response. Without reliable assay data, scientists may struggle to determine whether a drug candidate is effective, safe, or suitable for...
Developing a new pharmaceutical product involves much more than discovering a promising molecule or demonstrating its biological activity. A successful drug must also be manufactured consistently, remain stable under appropriate storage conditions, and meet established quality standards. This is where CMC drug development becomes an essential part of the pharmaceutical development process.
CMC...
The United States Genomic Biomarkers Market is gaining momentum as pharmaceutical companies, biotechnology firms, academic research centers, and diagnostic laboratories increasingly invest in precision medicine. Genomic biomarkers help identify genetic variations associated with diseases and provide insights that can support targeted treatment development and clinical research. Their...
The pharmaceutical market is expanding as rising disease prevalence, aging populations, healthcare access, and advances in drug development reshape treatment demand. The market was valued at USD 1,738.0 billion in 2025 and is estimated to reach USD 1,837.0 billion in 2026, before rising to USD 2,776.7 billion by 2033, representing a 6.1% CAGR from 2026 to 2033. The continued need for chronic...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek